McDermott Advises IK Partners on its Majority Stake in BIOBank

McDermott Will & Emery advised IK Partners on its acquisition of a majority stake, via its IK Small Cap III fund, in BIOBank, a leading manufacturer and distributor of bone allografts for orthopaedic, spinal, dental and cranio-maxillo-facial surgery, alongside management and the historical shareholders Verto Growth and Capital Croissance.

The McDermott team that advised IK Partners comprised:

• Diana Hund, Herschel Guez, partners, and Sarah Louifi, associate, on corporate aspects
• Sabine Naugès, Laurent Ayache, partners, and Zakarya Mahi, associate, on regulatory aspects
• Côme de Saint Vincent, Counsel, on tax aspects

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.